Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

#24-195 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#24-194 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

CapMan announces indicative tender offer results for its outstanding notes due 2025

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. CapMan PlcStock Exchange Release31 May 2024 at 18:00 EEST CapMan announces indicative tender offer results for its outstanding notes due 2025 CapMan Plc (the "Company") announces today the indicative results of the invitation to all holders of its outstanding EUR 50 million 4.000 per cent

Bluestep Bank AB (publ) has completed a covered bond tap issue of SEK 200 million

Bluestep Bank AB (publ) (“Bluestep Bank”) has completed a tap issue of SEK 200 million, related to the outstanding covered bond with maturity date November 19[th], 2027 (Loan 10, tranche 2, ISIN SE0020356350). The issue was made under Bluestep Bank’s MTCN-programme with a framework amount of SEK 15 billion. Following the tap issue, a total of SEK 1.2 billion is outstanding under loan 10 and a total of SEK 5.2 billion is outstanding under the programme. The issued bonds were priced at 101.425% plus accrued interest, corresponding to a re-offer spread of 3m Stibor + 0.46%. SEB acted

Panoro Energy ASA - Announces Transactions Made Under the Company’s Share Buyback Program

Oslo, 31 May 2024 – Panoro Energy ASA (“Panoro” or the “Company”) (OSE: PEN) initiated a share buyback program May 23, 2024 to repurchase up to 100 million of the Company’s common shares in open market transactions on the OSE pursuant to an agreement with Arctic Securities AS. For the period from and including 27 May through 31 May 2024, Panoro purchased a total of 200,000 shares at an average price of NOK 35.8829 per share. The transactions effected through the agreement with Arctic comprise all the transactions effected by or on behalf of the Company during the period. Transaction

Acroud publishes Annual Report for 2023

Acroud AB (publ) has today published its Annual Report for 2023 on the Company’s website, www.acroud.com. The report is available in both Swedish and English. For further information, please contact: Robert Andersson, President and CEO +356 9999 8017   Andrzej Mieszkowicz, CFO +356 99112090   ACROUD AB (publ) Telephone:     +356 2132 3750/1 E-mail:   info@acroud.com Website:  www.acroud.com  Certified Adviser: FNCA Sweden AB, info@fnca.se, +46 8 528 00 399     About ACROUD AB   ACROUD is a fast-growing global challenger that operates and

Change in number of shares and votes in Scandic

The number of shares and votes in Scandic Hotels Group AB (publ) (“Scandic”) has changed in May 2024 as a result of conversion of 325 of convertible bonds issued in 2021 to 749,502 of shares in Scandic.The total number of shares in Scandic has in May 2024 increased by 749,502 shares, corresponding to 749,502 votes. Today, the last trading day of the month, the total number of shares and votes in Scandic amounted to 192,053,618. For more information, please contact:Rasmus Blomqvist, Head of Investor Relations, Scandic Hotels GroupEmail: rasmus.blomqvist@scandichotels.comPhone: +46

Publication of a Prospectus

Regulatory Announcement RNS Number:  7063QRoyal Bank of CanadaMay 31, 2024 Publication of Prospectus Not for release, publication or distribution, directly or indirectly, in or into the United States. The following prospectus has been approved by the Financial Conduct Authority and is available for viewing: 6[th] Supplementary Notes Base Prospectus dated May 31, 2024 relating to the Programme for the Issuance of Securities of Royal Bank of Canada. The 6[th] Supplementary Notes Base Prospectus, together with the document incorporated by reference therein, have been

Publication of a Prospectus

Regulatory Announcement RNS Number:  7057QRoyal Bank of CanadaMay 31, 2024 Publication of Prospectus Not for release, publication or distribution, directly or indirectly, in or into the United States. The following prospectus has been approved by the Financial Conduct Authority and, along with the documents incorporated by reference therein, is available for viewing: 6[th] Supplementary Prospectus dated May 31, 2024 relating to the Programme for the €75,000,000,000 Global Covered Bond Programme of Royal Bank of Canada, unconditionally and irrevocably guaranteed as to

Dooba Finance AB (publ) – Publishing of the Quarter End Report for Q1 2024

On 27 October 2020, Dooba Finance AB (publ) (the “Company”) issued senior unsecured bonds in an amount of SEK 500.5 million guaranteed by Dooba Holdings Limited (the “Bonds”). On 22 March 2021, Dooba Finance AB (publ) (the “Company”) issued senior unsecured bonds in an amount of SEK 99 million under its existing framework of up to SEK 600 million senior unsecured bonds due 2024 (ISIN: NO0010895360) (the “Subsequent Bonds”).The Company today announces the publication of its Quarter End Report for Q1 2024. The report can be found at https://dfabbond.se/

NYAB decided on a share issue to complete the acquisition of Dyk & Anläggning Stockholm AB

NYAB PlcCOMPANY ANNOUNCEMENT31 May 2024 at 16:50NYAB decided on a share issue to complete the acquisition of Dyk & Anläggning Stockholm AB NYAB Plc has decided on the issuance of 2,334,770 new shares in the Company through a directed share issue. The share issue relates to a transaction, where NYAB has acquired all shares in Dyk & Anläggning Stockholm AB, a Swedish marine construction operator. Subscription price in the share issue was 0.48 euros per share and it was paid as an in-kind consideration with shares in Dyk & Anläggning Stockholm AB. With the directed share issue, total

Publication of the Annual Report 2023 of Misen Energy AB (publ)

The Annual Report for 2023 has been published today, is attached to this press release and is available in Swedish and English on the company’s website at: https://misenenergy.se/repository/Financial_reports_ENG/Misen_Energy_AR2023_ENG.pdf. The Annual Report for 2023 is also available at the company office at Kungsportsavenyen 32, SE-411 36 Gothenburg Sweden and can be ordered at info@misenenergy.se (%69%6e%66%6f@%6d%69%73%65%6e%65%6e%65%72%67%79.%73%65).

Mandatum plc: Managers’ Transactions (person closely associated with Rajaniemi)

Mandatum plc, Stock exchange release / Managers’ transactions, 31 of May 2024 at 4:30 p.m. EEST   Mandatum Oyj - Managers' Transactions - Person closely associated with Rajaniemi ________________________________ Person subject to the notification requirement Name: Oskari Rajaniemi Position: Closely associated person (1):Person Discharging Managerial Responsibilities In Issuer Name: Sanna Rajaniemi Position: Other senior manager Issuer: Mandatum Oyj LEI: 743700OAJK6L28Y2NN56 Notification type: INITIAL NOTIFICATION Reference number: 64759/5/4 _________

Auditor’s report

To the general meeting of the shareholders of Misen Energy AB (publ.)Corporate identity number 556526-3968Report on the annual accounts and consolidated accounts OpinionsWe have audited the annual accounts and consolidated accounts of Misen Energy AB (publ.) for the year 2023.  In our opinion, the annual accounts and consolidated accounts have been prepared in accordance with the Annual Accounts Act and present fairly, in all material respects, the financial position of parent company and the group as of 31 December 2023 and their financial performance and cash flow for the

Government loan converted into grant and generate positive income of SEK 9 million in the second quarter

FRI, MAY 31, 2024 15:10 CET In 2011, Heliospectra was granted a conditional loan of SEK 9 million by the Governmental Swedish Energy Agency. The Swedish Energy Agency has now decided to convert the loan into a grant.The decision means that Heliospectra's interest-bearing loan is reduced by SEK 9 million and the grant is reported as other income in the second quarter.

Change in number of Arise shares and votes

During May, the number of shares and votes in Arise AB (publ) has decreased due to the cancellation of own ordinary shares repurchased within the framework of the company’s buyback program which was resolved by the Annual General Meeting on 7 May, 2024. As of 31 May, 2024, the number of shares and votes in Arise AB (publ) amounts to 42,713,301. Halmstad, 31 May 2024 Arise AB (publ) For further information, please contact Per-Erik Eriksson, CEO Arise AB (publ), +46 702 409 902 The information in the press release is such that Arise AB (publ) is required to disclose pursuant to

Bittium Received a Purchase Order from the Finnish Defence Forces for Bittium TAC WIN™ and Bittium Tough VoIP™ System Support

Bittium Corporation Press Release Bittium Received a Purchase Order from the Finnish Defence Forces for Bittium TAC WIN™ and Bittium Tough VoIP™ System Support Bittium Corporation press release on May 31, 2024, at 3.30 p.m. (CEST +1) Bittium has received a purchase order from the Finnish Defence Forces for system support for the software-defined radio based Bittium Tactical Wireless IP Network™ (TAC WIN) system and Bittium Tough VoIP™ communication system. Both systems are meant for tactical communications. The purchase order applies to the year 2024 and includes technical

Correction - Beyond Frames Entertainment AB: Beyond Frames Entertainment AB (publ) Annual report and audit report for 2023

The auditor’s report was by mistake not attached to the original press releases; hence we are publishing a correction.The annual report and auditor's report for fiscal year 2023 are attached to this press release and are available on the company's website, www.beyondframes.com. Please note, the English version of the Annual report is an informal translation. In case of inconsistencies between the Swedish and the English text, the Swedish text shall prevail. It’s only the Swedish version of the Annual report that is audited, hence the attached auditor’s report is in Swedish.

Fondia Plc: Notification of Holdings According to Chapter 9, Section 10 of the Finnish Securities Market Act (Johan Hammarén)

Fondia Plc Company release 31.5.2024 at 3.00 p.m. EEST Fondia Plc has received on May 31, 2024 a notification pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act concerning substantial voting rights (hereinafter "the flagging"), according to which the number of shares controlled by Johan Hammarén in Fondia Plc exceeds 15 per cent of all shares. The flagging obligation applies to companies traded on the First North Growth Market Finland in a staggered transitional period following the amendment to the Act of April 19, 2024 (Act 163/2024 on amending the

Fondia Plc: Notification of Holdings According to Chapter 9, Section 10 of the Finnish Securities Market Act (Timo Lappi)

Fondia Plc Company release 31.5.2024 at 3.00 p.m. EEST Fondia Plc has received on May 31, 2024 a notification pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act concerning substantial voting rights (hereinafter "the flagging"), according to which the number of shares controlled by Timo Lappi in Fondia Plc exceeds 15 per cent of all shares. The flagging obligation applies to companies traded on the First North Growth Market Finland in a staggered transitional period following the amendment to the Act of April 19, 2024 (Act 163/2024 on amending the Securities

Brain+ A/S: Publication of investment brochure

Copenhagen, Denmark, 31 May 2024 – Brain+ A/S (Nasdaq First North: BRAINP) The Board of Directors of Brain+ A/S (“Brain+” or the “Company”) decided on 7 May 2024, with following approval from the Annual General Meeting held on 22 May 2024, to carry out a rights issue of units (the “Rights Issue”). The subscription period in the Rights Issue commences on 11 June 2024 and lasts until and including 24 June 2024. Brain+ has today published an investment brochure with information about the Company, its business, products and strategy, and about the Rights Issue. The investment brochure is

Hansa Biopharma Completes Randomization in Pivotal Phase 3 US ConfIdeS Trial

Lund, Sweden, 31 May, 2024. Hansa Biopharma AB, (“Hansa” or the “Company”) (Nasdaq Stockholm: HNSA), today announced recruitment and randomization in its US ConfIdeS trial is complete. ConfIdeS is a pivotal Phase 3 open label, randomized, controlled trial of imlifidase in kidney transplantation. Data from the trial is expected to support a Biologic License Application (BLA) submission under the accelerated approval pathway to the US Food and Drug Administration (FDA) in the second half of 2025. Søren Tulstrup, President and CEO, Hansa Biopharma said, “The randomization of 64 patients in

There are no items matching the current filter
There are no more items matching the current filter
Back to top